Achalasie, achalasia

Embed Size (px)

Citation preview

  • 8/12/2019 Achalasie, achalasia

    1/4

  • 8/12/2019 Achalasie, achalasia

    2/4

    weight loss and dysphagia to liquids. About 60 to 90% of patients regurgitate undigested food into the

    esophagus shortly after a meal. Regurgitation may cause nocturnal coughing and aspiration. About 30 to 50%

    of patients have chest pain associated with eating. Elderly patients may have had symptoms for months or

    years before diagnosis. Complications include weight loss with advanced disease and coughing,

    bronchospasm, and pneumonia from aspirating esophageal contents.

    Achalasia is often suspected from the history. In the early stages of the disease, chest x-ray findings can be

    normal. In the later stages, chest x-rays can show a dilated esophagus (mega-esophagus) with an air-fluid

    level caused by retained food and saliva. Elderly patients with a long history of achalasia can have a dilated

    and tortuous esophagus with a "bird-beak" narrowing at the gastroesophageal junction on barium swallow.

    Esophageal manometry usually shows the motility abnormalities.

    Endoscopy can eliminate the possibility of pseudo-achalasia, which should be considered when patients are >

    50 years, have had dysphagia for < 1 year, and have lost > 15 lb (> 7 kg). Other disorders that can mimic

    achalasia include malignancy, amyloidosis, sarcoidosis, Chagas disease, and postvagotomy disturbances.

    Achalasia must also be differentiated from diffuse esophageal spasm, which more typically affects younger

    patients.

    Treatment

    Treatment is directed at relieving symptoms and preventing complications. Various drugs that can decrease

    lower esophageal sphincter pressure (eg, anticholinergics, amyl nitrite, nitroglycerin, beta2-agonists) have

    been used, but results have been inconsistent. Anticholinergics are particularly difficult to use in the elderly

    because of their adverse effects. Isosorbide nitrate (5 to 10 mg po before meals) or nitroglycerin (0.4 mg

    sublingually 5 minutes before meals) rapidly decreases lower esophageal sphincter pressure and may lessen

    dysphagia during meals. However, most patients with achalasia require more definitive treatment.

    Botulinum toxin, an inhibitor of the release of acetylcholine, can be injected endoscopically into the lower

    esophageal sphincter. This relatively new treatment appears to approach the success rate of pneumatic

    dilatation. The most benefit seems to occur in patients > 50. The effects last 6 to 24 months; injection often

    needs to be repeated.

    Mechanical disruption of the lower esophageal sphincter using pneumatic dilatation or surgical myotomy has

    been the principle method of treatment when drug treatment and botulinum toxin have not been effective.

    About 60% of patients have a good response with pneumatic dilatation; success rates > 95% have been

    reported. Elderly patients and patients with a long history of achalasia seem to have the most favorable

    responses. Twenty to 40% of patients require repeated dilatations. The incidence of immediate complicationsis 1 to 16%. Perforation occurs in 1 to 13%; in most of these cases, the perforation is small and localized.

    Surgical myotomy is indicated when repeated pneumatic dilatations over a relatively short duration are

    necessary to maintain lower esophageal sphincter patency. Surgical myotomy reduces lower esophageal

    sphincter pressure more dependably than pneumatic dilatation but causes more complications. A modified

    Hellers procedure (anterior myotomy of the circular muscle fibers of the lower esophageal sphincter,

    preserving the sphincter competency) is successful in 80 to 90% of patients. This procedure is increasingly

    being performed laparoscopically or with video-assisted thorascopic surgery. The most significant

    complications are gastroesophageal reflux disease (< 10%) and persistence of severe dysphagia (< 10%).

    lasie http://www.med-info.nl/Afwijking_MDL - Slokdarm - acha

    7/14/2014

  • 8/12/2019 Achalasie, achalasia

    3/4

    Bron

    T. Yamada, D.H. Alpers,L. Laine, C. Owyang & D.W. Powell. Textbook of Gastroenterology 4th Ed.

    2003. Lippincott Williams & Wilkins.

    1.

    A. Fauci, E. Braunwald, D. Kasper, S. Hauser, D. Longo, J.L. Jameson & J. Loscalzo. Harrisons

    Principle of Internal Medicine 17th Ed. 2008. McGraw-Hill.

    2.

    A. Avunduk. Manual of Gastroenterology: Diagnosis and Therapy 4th Ed. 2008. Lippincott Williams &

    Wilkins.

    3.

    E. Kuntz & H.D. Kuntz. Hepatology, Principles and Practice 2nd Ed. 2006. Springer Science &

    Business Media.

    4.

    Laatste update: 5-09-2011

    lasie http://www.med-info.nl/Afwijking_MDL - Slokdarm - acha

    7/14/2014

  • 8/12/2019 Achalasie, achalasia

    4/4

    Advertenties

    Contact| Copyright| Disclaimer| Adverteren

    Site is ook geoptimaliseerd voor:

    Wij voldoen aan de HONcode, die staat voor betrouwbare informatie over gezondheid. Controleer hier

    lasie http://www.med-info.nl/Afwijking_MDL - Slokdarm - acha

    7/14/2014